0001209191-18-047467.txt : 20180817
0001209191-18-047467.hdr.sgml : 20180817
20180817171743
ACCESSION NUMBER: 0001209191-18-047467
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180815
FILED AS OF DATE: 20180817
DATE AS OF CHANGE: 20180817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SPECTOR STEVEN W
CENTRAL INDEX KEY: 0001170362
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-31161
FILM NUMBER: 181026530
MAIL ADDRESS:
STREET 1: ARENA PHARMACEUTICALS INC
STREET 2: 6166 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARENA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001080709
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232908305
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6154 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-453-7200
MAIL ADDRESS:
STREET 1: 6154 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-15
0
0001080709
ARENA PHARMACEUTICALS INC
ARNA
0001170362
SPECTOR STEVEN W
C/O ARENA PHARMACEUTICALS, INC.
6154 NANCY RIDGE ROAD
SAN DIEGO
CA
92121
0
1
0
0
EVP, General Counsel & Sec
Common Stock
2018-08-15
4
M
0
29005
18.10
A
48695
D
Common Stock
2018-08-15
4
S
0
25062
35.9041
D
23633
D
Common Stock
2018-08-15
4
S
0
3943
36.6919
D
19690
D
Employee Stock Option (right to buy)
18.10
2018-08-15
4
M
0
29005
0.00
D
2022-03-19
Common Stock
29005
5525
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.55 to $36.52, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.58 to $36.83, inclusive.
The options vested in four equal annual installments on March 19, 2013, 2014, 2015 and 2016, and were immediately exercisable once vested.
/s/ Steven W. Spector
2018-08-17